Current status and problems in the diagnosis and treatment of premenstrual syndrome and premenstrual dysphoric disorder from the perspective of obstetricians and gynecologists in Japan
Abstract:To investigate the current status and problems in the diagnosis and treatment of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) from the perspective of obstetricians and gynecologists (OB/GYNs) in Japan, the Japanese Society of Obstetrics and Gynecology (JSOG) conducted a national-wide survey. Methods: An email survey was sent to all JSOG members (16 732) and a webbased survey was conducted using a Google form between September and November 2021. The current status and problems in PMS/P… Show more
“…Questions (3), (4), (5), (6), and (7) were answered only by those routinely engaged in PMS/PMDD practice. The details of this question have already been described in a published paper 5 …”
Section: Methodsmentioning
confidence: 99%
“…(4) Support for life planning Looking only at the 123 facilities that treated patients with DSDs, 1.6% answered "sufficient," 16.3% answered "somewhat sufficient," 54.5% answered "somewhat insufficient," and 25.2% answered "insufficient" with regard to whether support was provided for life planning such as love, marriage, and pregnancy. (5) (3) Current status of cooperation between obstetrics and gynecology 59.8% of the respondents answered that they "have an obstetricians-gynecologists in their facility," 4.9% "in the same area," 6.1% "in the same city," and 13.4% "in the same prefecture," but 14.6% of them answered "don't know." Looking only at the 56 facilities that provided care for DSDs, 21.4% of the respondents answered that they were "well connected," 55.4% answered that they were "fairly well connected," 19.6% answered that they were "not so well connected," and 1.8% answered that they were "not connected."…”
Section: Methodsmentioning
confidence: 99%
“…(4) Support for life planning Looking at the 56 facilities that treated patients with DSDs, 0% of the respondents answered "sufficient," 7.1% answered "somewhat sufficient," 53.6% answered "somewhat insufficient," and 33.9% answered "insufficient" with regard to whether support was provided for life planning such as love, marriage, and pregnancy. (5) 4) Sexual intercourse, marriage, pregnancy, and childbirth Sexual partners were present in 9.6% of the respondents, and sexual intercourse was "no problem at all" in 3.4%, "somehow possible" in 0.7%, "somewhat difficult" in 2.7%, "difficult" in 4.1%, and "no response" in 89.0%. Marriage was found in 6.8%, pregnancy in 2.1%, and childbirth in 1.4% of the patients.…”
The Women's Health Care Committee was established in 2010 with the goal of improving women's health. In the current academic year, there are six subcommittees focusing on conducting the following surveys: (1) the current status of pregnancy‐associated breast cancer in Japan; (2) surgery for disorders of sex development; (3) diagnosis and treatment of premenstrual syndrome and premenstrual dysphoric disorder; (4) obstetrics and gynecology‐based treatment for patients with eating disorders in Japan; (5) multi‐drug‐resistant bacterial infections in the field of obstetrics and gynecology; and (6) changing the methodology of the treatment of dysmenorrhea and continuing medical education. The activities of each subcommittee are described below. This report is based on the Japanese version of the annual report (Acta Obst Gynaec Jpn 2023;75(6):662–86).
“…Questions (3), (4), (5), (6), and (7) were answered only by those routinely engaged in PMS/PMDD practice. The details of this question have already been described in a published paper 5 …”
Section: Methodsmentioning
confidence: 99%
“…(4) Support for life planning Looking only at the 123 facilities that treated patients with DSDs, 1.6% answered "sufficient," 16.3% answered "somewhat sufficient," 54.5% answered "somewhat insufficient," and 25.2% answered "insufficient" with regard to whether support was provided for life planning such as love, marriage, and pregnancy. (5) (3) Current status of cooperation between obstetrics and gynecology 59.8% of the respondents answered that they "have an obstetricians-gynecologists in their facility," 4.9% "in the same area," 6.1% "in the same city," and 13.4% "in the same prefecture," but 14.6% of them answered "don't know." Looking only at the 56 facilities that provided care for DSDs, 21.4% of the respondents answered that they were "well connected," 55.4% answered that they were "fairly well connected," 19.6% answered that they were "not so well connected," and 1.8% answered that they were "not connected."…”
Section: Methodsmentioning
confidence: 99%
“…(4) Support for life planning Looking at the 56 facilities that treated patients with DSDs, 0% of the respondents answered "sufficient," 7.1% answered "somewhat sufficient," 53.6% answered "somewhat insufficient," and 33.9% answered "insufficient" with regard to whether support was provided for life planning such as love, marriage, and pregnancy. (5) 4) Sexual intercourse, marriage, pregnancy, and childbirth Sexual partners were present in 9.6% of the respondents, and sexual intercourse was "no problem at all" in 3.4%, "somehow possible" in 0.7%, "somewhat difficult" in 2.7%, "difficult" in 4.1%, and "no response" in 89.0%. Marriage was found in 6.8%, pregnancy in 2.1%, and childbirth in 1.4% of the patients.…”
The Women's Health Care Committee was established in 2010 with the goal of improving women's health. In the current academic year, there are six subcommittees focusing on conducting the following surveys: (1) the current status of pregnancy‐associated breast cancer in Japan; (2) surgery for disorders of sex development; (3) diagnosis and treatment of premenstrual syndrome and premenstrual dysphoric disorder; (4) obstetrics and gynecology‐based treatment for patients with eating disorders in Japan; (5) multi‐drug‐resistant bacterial infections in the field of obstetrics and gynecology; and (6) changing the methodology of the treatment of dysmenorrhea and continuing medical education. The activities of each subcommittee are described below. This report is based on the Japanese version of the annual report (Acta Obst Gynaec Jpn 2023;75(6):662–86).
Background and AimsMany women reported experiencing abnormalities in their cycle after being vaccinated with Covid‐19 vaccination. To understand this issue further, our study aimed to evaluate the menstrual cycle patterns among women of childbearing age after receiving COVID‐19 vaccinations.MethodsA cross‐sectional study was conducted to investigate the impact of COVID‐19 vaccine on women aged 18 years and above in Saudi Arabia. A self‐administered online questionnaire was distributed among participants who had received at least one dose of COVID‐19 vaccine. The questionnaire included questions about the participants' demographic characteristics, medical history, and vaccine‐related adverse events.ResultsThe study included 383 female participants with an average age of 30.8 ± 8.1 years. The majority of participants, 92.7%, were Saudi, and more than half, 51.4%, were single. Of the participants, 78.9% were disease‐free, and a majority of 67.9% had no history of Coronavirus Disease 2019 infection. A significant proportion of participants reported postvaccination changes in the menstrual cycle. Specifically, 43.1% reported changes after the first dose, and 38.4% reported changes after the second dose (p = 0.044). The severity of premenstrual symptoms increased from 44 (11.5%) to 113 (29.5%) after the first dose. Reported pain on the (WONG‐BAKER) scale was also significantly elevated from 34 (8.9%) to 87 (22.7%) (p < 0.001) after the first dose.ConclusionA relatively high prevalence of menstrual cycle irregularities was reported by Saudi vaccinated women, particularly young adults. These findings suggest the need to further research and explore the underlying causes of these irregularities and develop interventions that may help mitigate their impact on women's health. It is also recommended that women who observe long‐term changes in their menstrual cycles seek follow‐up and consultation with healthcare providers to ensure that any potential health concerns are addressed promptly.
AimTo investigate and compare the diagnoses and treatment of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) from the perspectives of psychiatrists and obstetricians/gynecologists (OB/GYNs) in Japan.MethodsBetween December 2021 and February 2022, a web‐based survey was conducted among the members of the Japanese Association of Neuro‐Psychiatric Clinics. Data from 262 psychiatrists who responded to the aforementioned survey were compared with data from 409 OB/GYNs from a survey conducted in 2021 among members of the Japanese Society of Obstetrics and Gynecology.ResultsOverall, 79.8% of psychiatrists and 97.3% of OB/GYNs were involved in practicing PMS/PMDD diagnosis and treatment. Most psychiatrists believed that PMS should be treated by OB/GYNs (74.4%) and PMDD by psychiatrists (75.6%). Only vague medical interviews were conducted by 86.6% of psychiatrists, and only 9.7% maintained a two‐cycle symptom diary. Psychiatrists mostly prescribed selective serotonin/serotonin and noradrenaline reuptake inhibitor (SSRI/SNRI) continuous dosing (91.1%), followed by Kampo medicines, especially Kamishoyosan (73.3%); only 2.8% chose oral contraceptive pills, unlike OB/GYNs, while SSRI continuous (32.8%) and luteal phase dosing (20.6%) and Kampo medicine (42.1%) were the most common first‐line treatments. Lifestyle guidance was prescribed by 63.6% of psychiatrists, followed by cognitive behavioral therapy (13.8%) and the symptom diary observation method (11.1%), which were similar to OB/GYNs' choices.ConclusionsMany Japanese psychiatrists and OB/GYNs do not base PMS/PMDD diagnoses on prospective monitoring methods using specific diagnostic criteria and therefore do not provide evidence‐based treatment. Moreover, a tendency of being biased toward treatments in which the department specialized was observed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
